Topics

Opioid Litigation Looms Over Walgreens Leveraged Buyout

07:30 EST 7 Nov 2019 | Forbes

Settlements by Walgreens of opioid litigation could play into any decision of private equity firms to finance a leveraged buyout of the drugstore chain.

Original Article: Opioid Litigation Looms Over Walgreens Leveraged Buyout

NEXT ARTICLE

More From BioPortfolio on "Opioid Litigation Looms Over Walgreens Leveraged Buyout"

Quick Search